DBS Second-Quarter Net Rose on Higher Interest Income
By P.R. Venkat
DBS Group's second-quarter net profit rose 45% on year, supported mainly by higher net interest income and fees.
Net profit for the quarter was 2.63 billion Singapore dollars ($1.96 billion), DBS Group said Thursday.
Total income was up 35% on year at S$5.05 billion with net interest coming in 54% higher at S$3.58 billion. The bank, one of Southeast Asia's largest by assets, said net fee and commission income rose 7.0% on year to S$823 million.
Allowances for credit and other losses during the second quarter were S$72 million, down 55% on quarter, but up 57% on year.
For the first half, the bank's net profit rose 44% on year to S$5.20 billion.
DBS Chief Executive Piyush Gupta said that loan growth for the year will be in low single digits and there was an upside bias to net interest margin from current levels.
The bank's board declared a dividend of 48 Singapore cents a share for the second quarter, bringing the first-half dividend to 90 Singapore cents a share.
Write to P.R. Venkat at venkat.pr@wsj.com
(END) Dow Jones Newswires
August 02, 2023 19:35 ET (23:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track